Global Antibody Drug Conjugates Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

January 2019 | 129 pages | ID: GA5A1117CE7EN
GlobalInfoResearch

Abstracts

Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. 

Scope of the Report:

This report focuses on the Antibody Drug Conjugates in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement in the clinical data and technological advancements in the field of drug development shelling out innovative drugs into the market.
The worldwide market for Antibody Drug Conjugates is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• F. Hoffman-La Roche
• Novartis AG
• Takeda Pharmaceutical
• Pfizer
• Seattle Genetics
• Genentech
• Immunogen
• Progenics Pharmaceuticals
• Bayer Healthcare Pharmaceuticals

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Adcetris
• Kadcyla

Market Segment by Applications, can be divided into

• Breast Cancer
• Lymphoma

There are 15 Chapters to deeply display the global Antibody Drug Conjugates market.
Chapter 1, to describe Antibody Drug Conjugates Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antibody Drug Conjugates, with sales, revenue, and price of Antibody Drug Conjugates, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antibody Drug Conjugates, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Antibody Drug Conjugates market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Antibody Drug Conjugates sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Antibody Drug Conjugates Introduction
1.2 Market Analysis by Type
  1.2.1 Adcetris
  1.2.2 Kadcyla
1.3 Market Analysis by Applications
  1.3.1 Breast Cancer
  1.3.2 Lymphoma
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 F. Hoffman-La Roche
  2.1.1 Business Overview
  2.1.2 Antibody Drug Conjugates Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 F. Hoffman-La Roche Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis AG
  2.2.1 Business Overview
  2.2.2 Antibody Drug Conjugates Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Novartis AG Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Takeda Pharmaceutical
  2.3.1 Business Overview
  2.3.2 Antibody Drug Conjugates Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Takeda Pharmaceutical Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
  2.4.1 Business Overview
  2.4.2 Antibody Drug Conjugates Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Pfizer Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Seattle Genetics
  2.5.1 Business Overview
  2.5.2 Antibody Drug Conjugates Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Seattle Genetics Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Genentech
  2.6.1 Business Overview
  2.6.2 Antibody Drug Conjugates Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Genentech Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Immunogen
  2.7.1 Business Overview
  2.7.2 Antibody Drug Conjugates Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Immunogen Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Progenics Pharmaceuticals
  2.8.1 Business Overview
  2.8.2 Antibody Drug Conjugates Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Progenics Pharmaceuticals Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bayer Healthcare Pharmaceuticals
  2.9.1 Business Overview
  2.9.2 Antibody Drug Conjugates Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL ANTIBODY DRUG CONJUGATES SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Antibody Drug Conjugates Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antibody Drug Conjugates Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Antibody Drug Conjugates Manufacturer Market Share in 2017
  3.3.2 Top 6 Antibody Drug Conjugates Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL ANTIBODY DRUG CONJUGATES MARKET ANALYSIS BY REGIONS

4.1 Global Antibody Drug Conjugates Sales, Revenue and Market Share by Regions
  4.1.1 Global Antibody Drug Conjugates Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Antibody Drug Conjugates Revenue and Market Share by Regions (2013-2018)
4.2 North America Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
4.3 Europe Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
4.5 South America Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antibody Drug Conjugates Sales and Growth Rate (2013-2018)

5 NORTH AMERICA ANTIBODY DRUG CONJUGATES BY COUNTRIES

5.1 North America Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
  5.1.1 North America Antibody Drug Conjugates Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Antibody Drug Conjugates Revenue and Market Share by Countries (2013-2018)
5.2 United States Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
5.3 Canada Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
5.4 Mexico Antibody Drug Conjugates Sales and Growth Rate (2013-2018)

6 EUROPE ANTIBODY DRUG CONJUGATES BY COUNTRIES

6.1 Europe Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
  6.1.1 Europe Antibody Drug Conjugates Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Antibody Drug Conjugates Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
6.3 UK Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
6.4 France Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
6.5 Russia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
6.6 Italy Antibody Drug Conjugates Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC ANTIBODY DRUG CONJUGATES BY COUNTRIES

7.1 Asia-Pacific Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Antibody Drug Conjugates Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Antibody Drug Conjugates Revenue and Market Share by Countries (2013-2018)
7.2 China Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
7.3 Japan Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
7.4 Korea Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
7.5 India Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA ANTIBODY DRUG CONJUGATES BY COUNTRIES

8.1 South America Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
  8.1.1 South America Antibody Drug Conjugates Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Antibody Drug Conjugates Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
8.3 Argentina Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
8.4 Colombia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA ANTIBODY DRUG CONJUGATES BY COUNTRIES

9.1 Middle East and Africa Antibody Drug Conjugates Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Antibody Drug Conjugates Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Antibody Drug Conjugates Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
9.3 UAE Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
9.4 Egypt Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
9.5 Nigeria Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
9.6 South Africa Antibody Drug Conjugates Sales and Growth Rate (2013-2018)

10 GLOBAL ANTIBODY DRUG CONJUGATES MARKET SEGMENT BY TYPE

10.1 Global Antibody Drug Conjugates Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Antibody Drug Conjugates Sales and Market Share by Type (2013-2018)
  10.1.2 Global Antibody Drug Conjugates Revenue and Market Share by Type (2013-2018)
10.2 Adcetris Sales Growth and Price
  10.2.1 Global Adcetris Sales Growth (2013-2018)
  10.2.2 Global Adcetris Price (2013-2018)
10.3 Kadcyla Sales Growth and Price
  10.3.1 Global Kadcyla Sales Growth (2013-2018)
  10.3.2 Global Kadcyla Price (2013-2018)

11 GLOBAL ANTIBODY DRUG CONJUGATES MARKET SEGMENT BY APPLICATION

11.1 Global Antibody Drug Conjugates Sales Market Share by Application (2013-2018)
11.2 Breast Cancer Sales Growth (2013-2018)
11.3 Lymphoma Sales Growth (2013-2018)

12 ANTIBODY DRUG CONJUGATES MARKET FORECAST (2018-2023)

12.1 Global Antibody Drug Conjugates Sales, Revenue and Growth Rate (2018-2023)
12.2 Antibody Drug Conjugates Market Forecast by Regions (2018-2023)
  12.2.1 North America Antibody Drug Conjugates Market Forecast (2018-2023)
  12.2.2 Europe Antibody Drug Conjugates Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Antibody Drug Conjugates Market Forecast (2018-2023)
  12.2.4 South America Antibody Drug Conjugates Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Antibody Drug Conjugates Market Forecast (2018-2023)
12.3 Antibody Drug Conjugates Market Forecast by Type (2018-2023)
  12.3.1 Global Antibody Drug Conjugates Sales Forecast by Type (2018-2023)
  12.3.2 Global Antibody Drug Conjugates Market Share Forecast by Type (2018-2023)
12.4 Antibody Drug Conjugates Market Forecast by Application (2018-2023)
  12.4.1 Global Antibody Drug Conjugates Sales Forecast by Application (2018-2023)
  12.4.2 Global Antibody Drug Conjugates Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Antibody Drug Conjugates Picture
Table Product Specifications of Antibody Drug Conjugates
Figure Global Sales Market Share of Antibody Drug Conjugates by Types in 2017
Table Antibody Drug Conjugates Types for Major Manufacturers
Figure Adcetris Picture
Figure Kadcyla Picture
Figure Antibody Drug Conjugates Sales Market Share by Applications in 2017
Figure Breast Cancer Picture
Figure Lymphoma Picture
Figure United States Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure France Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure UK Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure China Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure India Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Antibody Drug Conjugates Revenue (Value) and Growth Rate (2013-2023)
Table F. Hoffman-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffman-La Roche Antibody Drug Conjugates Type and Applications
Table F. Hoffman-La Roche Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Antibody Drug Conjugates Type and Applications
Table Novartis AG Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Antibody Drug Conjugates Type and Applications
Table Takeda Pharmaceutical Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Antibody Drug Conjugates Type and Applications
Table Pfizer Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table Seattle Genetics Antibody Drug Conjugates Type and Applications
Table Seattle Genetics Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genentech Basic Information, Manufacturing Base and Competitors
Table Genentech Antibody Drug Conjugates Type and Applications
Table Genentech Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Immunogen Basic Information, Manufacturing Base and Competitors
Table Immunogen Antibody Drug Conjugates Type and Applications
Table Immunogen Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Progenics Pharmaceuticals Antibody Drug Conjugates Type and Applications
Table Progenics Pharmaceuticals Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Healthcare Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Type and Applications
Table Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Antibody Drug Conjugates Sales by Manufacturer (2016-2017)
Figure Global Antibody Drug Conjugates Sales Market Share by Manufacturer in 2016
Figure Global Antibody Drug Conjugates Sales Market Share by Manufacturer in 2017
Table Global Antibody Drug Conjugates Revenue by Manufacturer (2016-2017)
Figure Global Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2016
Figure Global Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2017
Figure Top 3 Antibody Drug Conjugates Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Antibody Drug Conjugates Manufacturer (Revenue) Market Share in 2017
Figure Global Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Global Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Table Global Antibody Drug Conjugates Sales by Regions (2013-2018)
Table Global Antibody Drug Conjugates Sales Market Share by Regions (2013-2018)
Table Global Antibody Drug Conjugates Revenue by Regions (2013-2018)
Figure Global Antibody Drug Conjugates Revenue Market Share by Regions in 2013
Figure Global Antibody Drug Conjugates Revenue Market Share by Regions in 2017
Figure North America Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Europe Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure South America Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure North America Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Table North America Antibody Drug Conjugates Sales by Countries (2013-2018)
Table North America Antibody Drug Conjugates Sales Market Share by Countries (2013-2018)
Figure North America Antibody Drug Conjugates Sales Market Share by Countries in 2013
Figure North America Antibody Drug Conjugates Sales Market Share by Countries in 2017
Table North America Antibody Drug Conjugates Revenue by Countries (2013-2018)
Table North America Antibody Drug Conjugates Revenue Market Share by Countries (2013-2018)
Figure North America Antibody Drug Conjugates Revenue Market Share by Countries in 2013
Figure North America Antibody Drug Conjugates Revenue Market Share by Countries in 2017
Figure United States Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Canada Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Mexico Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Europe Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Table Europe Antibody Drug Conjugates Sales by Countries (2013-2018)
Table Europe Antibody Drug Conjugates Sales Market Share by Countries (2013-2018)
Table Europe Antibody Drug Conjugates Revenue by Countries (2013-2018)
Figure Europe Antibody Drug Conjugates Revenue Market Share by Countries in 2016
Figure Europe Antibody Drug Conjugates Revenue Market Share by Countries in 2017
Figure Germany Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure UK Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure France Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Russia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Italy Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Antibody Drug Conjugates Sales by Countries (2013-2018)
Table Asia-Pacific Antibody Drug Conjugates Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Antibody Drug Conjugates Sales Market Share by Countries 2017
Table Asia-Pacific Antibody Drug Conjugates Revenue by Countries (2013-2018)
Figure Asia-Pacific Antibody Drug Conjugates Revenue Market Share by Countries 2017
Figure China Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Japan Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Korea Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure India Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Southeast Asia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure South America Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Table South America Antibody Drug Conjugates Sales by Countries (2013-2018)
Table South America Antibody Drug Conjugates Sales Market Share by Countries (2013-2018)
Figure South America Antibody Drug Conjugates Sales Market Share by Countries in 2017
Table South America Antibody Drug Conjugates Revenue by Countries (2013-2018)
Table South America Antibody Drug Conjugates Revenue Market Share by Countries (2013-2018)
Figure South America Antibody Drug Conjugates Revenue Market Share by Countries in 2017
Figure Brazil Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Argentina Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Colombia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Antibody Drug Conjugates Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Sales by Countries (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Antibody Drug Conjugates Sales Market Share by Countries in 2017
Table Middle East and Africa Antibody Drug Conjugates Revenue by Countries (2013-2018)
Table Middle East and Africa Antibody Drug Conjugates Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Antibody Drug Conjugates Revenue Market Share by Countries in 2013
Figure Middle East and Africa Antibody Drug Conjugates Revenue Market Share by Countries in 2017
Figure Saudi Arabia Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure UAE Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Egypt Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure Nigeria Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Figure South Africa Antibody Drug Conjugates Sales and Growth Rate (2013-2018)
Table Global Antibody Drug Conjugates Sales by Type (2013-2018)
Table Global Antibody Drug Conjugates Sales Share by Type (2013-2018)
Table Global Antibody Drug Conjugates Revenue by Type (2013-2018)
Table Global Antibody Drug Conjugates Revenue Share by Type (2013-2018)
Figure Global Adcetris Sales Growth (2013-2018)
Figure Global Adcetris Price (2013-2018)
Figure Global Kadcyla Sales Growth (2013-2018)
Figure Global Kadcyla Price (2013-2018)
Table Global Antibody Drug Conjugates Sales by Application (2013-2018)
Table Global Antibody Drug Conjugates Sales Share by Application (2013-2018)
Figure Global Lymphoma Sales Growth (2013-2018)
Figure Global Antibody Drug Conjugates Sales, Revenue and Growth Rate (2018-2023)
Table Global Antibody Drug Conjugates Sales Forecast by Regions (2018-2023)
Table Global Antibody Drug Conjugates Market Share Forecast by Regions (2018-2023)
Figure North America Sales Antibody Drug Conjugates Market Forecast (2018-2023)
Figure Europe Sales Antibody Drug Conjugates Market Forecast (2018-2023)
Figure Asia-Pacific Sales Antibody Drug Conjugates Market Forecast (2018-2023)
Figure South America Sales Antibody Drug Conjugates Market Forecast (2018-2023)
Figure Middle East and Africa Sales Antibody Drug Conjugates Market Forecast (2018-2023)
Table Global Antibody Drug Conjugates Sales Forecast by Type (2018-2023)
Table Global Antibody Drug Conjugates Market Share Forecast by Type (2018-2023)
Table Global Antibody Drug Conjugates Sales Forecast by Application (2018-2023)
Table Global Antibody Drug Conjugates Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List